Pharmacy
As recommended by the AHA, the Food and Drug Administration proposed revising 2016 draft guidance to allow hospital and health system pharmacies that are not outsourcing facilities to distribute compounded drug products to any health care facility in the same system without first receiving a valid…
Fourteen leading U.S. drug companies from 2016 to 2020 spent $577 billion on stock buybacks and dividends, $56 billion more than they spent on research and development over the same period, according to a report released by the House Committee on Oversight and Reform.
SIF Webinar: State White Bagging and State Legislation resources.
Regulators should prohibit health insurers from preventing hospitals and physicians in their networks from directly acquiring and storing drugs used in patient care, according to a white paper released today by AHA.
Letter to Centers for Medicare & Medicaid Services, expressing deep concerns regarding a series of UnitedHealthcare health plan coverage policies.
COVID-19 continues to dramatically impact the short- and long-term strategies of hospitals and health systems.
.webreplay{
border: solid 2px #777;
padding: 15px 5px;
margin: 0 0 10px 15px;
}
@media (min-width:360px){
.webreplay{
min-width: 290px;
float: right;
}
}
On-demand Webinar
MktoForms2.loadForm("//app-sj20.marketo.com", "734-ZTO-041", 5774);
Pharmacy Benefit…
Amazon continues to grow its partnerships with health care technology companies as it expands its access points with consumers. The latest move: a deal with drug and medical database company First Databank (FDB) that will allow Amazon’s Alexa voice-assistant users to ask for information on the 1,…
The United States Pharmacopeia (USP) in June 2019 released several new and revised pharmacy compounding standards. Specifically, USP published the final revised version of general chapter <797> (Pharmaceutical Compounding of Sterile Preparations) to accompany the previous released general…
A list of items to consider in preparing to comply with new standards for the handling of hazardous drugs set forth in USP general Chapter 800.